Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 288

1.

Effects of growth hormone on serum lipids and lipoproteins: possible significance of increased peripheral conversion of thyroxine to triiodothyronine.

Wolthers T, Lemming L, Grøfte T, Møller N, Christiansen JS, Klausen IC, Jørgensen JO.

Metabolism. 1996 Aug;45(8):1016-20.

PMID:
8769362
2.

Calorigenic effects of growth hormone: the role of thyroid hormones.

Wolthers T, Grøftne T, Møller N, Christiansen JS, Orskov H, Weeke J, Jørgensen JO.

J Clin Endocrinol Metab. 1996 Apr;81(4):1416-9.

PMID:
8636344
4.
5.

The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.

Elgzyri T, Castenfors J, Hägg E, Backman C, Thorén M, Bramnert M.

Clin Endocrinol (Oxf). 2004 Jul;61(1):113-22.

PMID:
15212653
6.

Serum leptin concentrations during short-term administration of growth hormone and triiodothyronine in healthy adults: a randomised, double-blind placebo-controlled study.

Wolthers T, Lechuga A, Grøfte T, Nørrelund H, Møller N, Christiansen JS, Jørgensen JO.

Horm Metab Res. 1999 Jan;31(1):37-40.

PMID:
10077348
7.

Effects of growth hormone administration on fuel oxidation and thyroid function in normal man.

Møller J, Jørgensen JO, Møller N, Christiansen JS, Weeke J.

Metabolism. 1992 Jul;41(7):728-31.

PMID:
1619991
8.

Differential effects of growth hormone and prednisolone on energy metabolism and leptin levels in humans.

Wolthers T, Grøfte T, Nørrelund H, Poulsen PL, Andreasen F, Christiansen JS, Jørgensen JO.

Metabolism. 1998 Jan;47(1):83-8.

PMID:
9440482
9.

Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency.

Cuneo RC, Salomon F, Watts GF, Hesp R, Sönksen PH.

Metabolism. 1993 Dec;42(12):1519-23.

PMID:
8246764
10.

Low dose continuously infused growth hormone results in increased lipoprotein(a) and decreased low density lipoprotein cholesterol concentrations in middle-aged men.

Oscarsson J, Ottosson M, Wiklund O, Mårin P, Vikman-Adolfsson K, Björntorp P, Edén S.

Clin Endocrinol (Oxf). 1994 Jul;41(1):109-16.

PMID:
8050123
11.
12.

Effects of growth hormone and/or testosterone on very low density lipoprotein apolipoprotein B100 kinetics and plasma lipids in healthy elderly men: a randomised controlled trial.

Giannoulis MG, Jackson N, Shojaee-Moradie F, Sonksen PH, Martin FC, Umpleby AM.

Growth Horm IGF Res. 2006 Oct-Dec;16(5-6):308-17. Epub 2006 Oct 9.

PMID:
17029996
13.

Effects of long-term growth hormone (GH) and triiodothyronine (T3) administration on functional hepatic nitrogen clearance in normal man.

Wolthers T, Grøfte T, Møller N, Vilstrup H, Jørgensen JO.

J Hepatol. 1996 Mar;24(3):313-9.

PMID:
8778198
14.

The IGF-I response to very low rhGH doses is preserved in human ageing.

Arvat E, Ceda G, Ramunni J, Lanfranco F, Aimaretti G, Gianotti L, Broglio F, Ghigo E.

Clin Endocrinol (Oxf). 1998 Dec;49(6):757-63.

PMID:
10209563
15.

Effect of short-term treatment with recombinant human growth hormone on lipids and lipoproteins in women and men without growth hormone disturbances.

Hansen PS, Kassem M, Brixen K, Klausen IC, Mosekilde L, Faergeman O.

Metabolism. 1995 Jun;44(6):725-9.

PMID:
7783656
16.
18.
19.

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Hartgens F, Rietjens G, Keizer HA, Kuipers H, Wolffenbuttel BH.

Br J Sports Med. 2004 Jun;38(3):253-9.

20.

Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and Apo(a) and ApoE phenotypes.

Johannsson G, Oscarsson J, Rosén T, Wiklund O, Olsson G, Wilhelmsen L, Bengtsson BA.

Arterioscler Thromb Vasc Biol. 1995 Dec;15(12):2142-50.

Supplemental Content

Support Center